Handok to launch Teveten, an anti-hypertension drug.
Teveten is a new alpha receptor blocker having a dual mode of action, which shows the angiotensin II receptor blocking (RAAS) with sympathetic nerve blocking...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
